The Correlation Between B-type Natriuretic Peptide (BNP) and Global End Diastolic Volume
The Correlation Between BNP and Global End Diastolic Volume
1 other identifier
observational
46
1 country
1
Brief Summary
The investigators hypothesized that the serum B-type Natriuretic Peptide (BNP) level may be correlated with global end diastolic volume (GEDV) as measured by transpulmonary thermodilution technique (PiCCO). The rationale is that some animal studies have proven that BNP is released from ventricular myocardium in response to physical expansion. Such physical expansion can be measured by GEDV. If the hypothesis can be confirmed with our study, the serum level BNP can be used to monitor volume status of critically ill patient, instead of the invasive monitoring system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 27, 2011
CompletedFirst Posted
Study publicly available on registry
April 29, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedApril 4, 2013
September 1, 2012
1.3 years
April 27, 2011
April 1, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
global end diastolic volume
this is measured by transpulmonary thermodilution technique
within 12 h after measurement of BNP
Study Arms (1)
consecutive patients
there is only one group in our study
Eligibility Criteria
critically ill patients who required hemodynamic monitoring using PiCCO
You may qualify if:
- critically ill patients who required hemodynamic monitoring using PiCCO
You may not qualify if:
- patients with renal dysfunction
- those older than 80 years
- pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jinhua central hospital
Jinhua, Zhejiang, 321000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Zhongheng Zhang, MD
Jinhua Central Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
April 27, 2011
First Posted
April 29, 2011
Study Start
June 1, 2010
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
April 4, 2013
Record last verified: 2012-09